An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Donatello, Simona ^a   Hudson, Lance ^a   Cottell, David C ^b   Blanco, Alfonso ^b   Aurrekoetxea, Igor ^a,c   Shelly, Martin J ^d   Dervan, Peter A ^d   Kell, Malcolm R ^d   Stokes, Maurice ^d   Hill, Arnold D K ^a   Hopkins, Ann M ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF NAVARRA   (Spain)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LIPOFUSCIN; ACTIN; FLOTILLINS; KERATIN TYPE I; MEMBRANE PROTEIN; TUMOR MARKER; VIMENTIN;

AGING; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL CULTURE; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN MCF 10A; CELL STRAIN MDA MB 231; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOEPITHELIUM; PRIORITY JOURNAL; PROGNOSIS; SENESCENCE; STEM CELL; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY; BREAST TUMOR; CANCER STEM CELL; CELL AGING; CELL SHAPE; CULTURE TECHNIQUE; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; ULTRASTRUCTURE;

ACTINS; BREAST NEOPLASMS; CELL AGING; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SHAPE; FEMALE; HUMANS; KERATINS, TYPE I; MEMBRANE PROTEINS; NEOPLASTIC STEM CELLS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 79955089434     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-45     Document Type: Article

References (28)

1. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. G Molyneux FC Geyer FA Magnay A McCarthy H Kendrick R Natrajan A Mackay A Grigoriadis A Tutt A Ashworth, et al. Cell Stem Cell 7 403 417
2. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. M Kakarala MS Wicha, J Clin Oncol 2008 26 2813 2820 10.1200/JCO.2008.16.3931 18539959
3. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. J Stingl CJ Eaves U Kuusk JT Emerman, Differentiation 1998 63 201 213 10.1111/j.1432-0436.1998. 00201.x 9745711 (Pubitemid 28428734)
4. Growth and differentiation of progenitor/stem cells derived from the human mammary gland. H Clayton I Titley M Vivanco, Exp Cell Res 2004 297 444 460 10.1016/j.yexcr.2004.03.029 15212947 (Pubitemid 38798406)
5. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. C Ginestier MH Hur E Charafe-Jauffret F Monville J Dutcher M Brown J Jacquemier P Viens CG Kleer S Liu, et al. Cell Stem Cell 2007 1 555 567 10.1016/j.stem.2007.08.014 18371393 (Pubitemid 350056407)
6. Mammary epithelial stem cells. GH Smith G Chepko, Microsc Res Tech 2001 52 190 203 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O 11169867 (Pubitemid 32107807)
7. Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. C Pechoux T Gudjonsson L Ronnov-Jessen MJ Bissell OW Petersen, Dev Biol 1999 206 88 99 10.1006/dbio.1998.9133 9918697 (Pubitemid 29069876)
8. Human mammary epithelial cells in culture: differentiation and transformation. MR Stampfer JC Bartley, Cancer Treat Res 1988 40 1 24 2908647
9. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. GP Dimri X Lee G Basile M Acosta G Scott C Roskelley EE Medrano M Linskens I Rubelj O Pereira-Smith, et al. Proc Natl Acad Sci USA 1995 92 9363 9367 10.1073/pnas.92.20.9363 7568133
10. Principles and Techniques of Electron Microscopy. M Hayat, London: Macmillan press 1987
11. p63: revving up epithelial stem-cell potential. C Blanpain E Fuchs, Nat Cell Biol 2007 9 731 733 10.1038/ncb0707-731 17603506 (Pubitemid 47019456)
12. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. J Stingl CJ Eaves I Zandieh JT Emerman, Breast Cancer Res Treat 2001 67 93 109 10.1023/A:1010615124301 11519870 (Pubitemid 32744490)
13. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. V Neumeister S Agarwal J Bordeaux RL Camp DL Rimm, Am J Pathol 176 2131 2138
14. Growth of normal human mammary cells in culture. M Stampfer RC Hallowes AJ Hackett, In Vitro 1980 16 415 425 10.1007/BF02618365 6993343 (Pubitemid 11250260)
15. Large expansion of morphologically heterogeneous mammary epithelial cells, including the luminal phenotype, from human breast tumours. L Krasna D Dudorkinova J Vedralova P Vesely E Pokorna I Kudlackova A Chaloupkova L Petruzelka J Danes E Matouskova, Breast Cancer Res Treat 2002 71 219 235 10.1023/A:1014457731494 12002341 (Pubitemid 34263986)
16. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. SP Ethier ML Mahacek WJ Gullick TS Frank BL Weber, Cancer Res 1993 53 627 635 8425198 (Pubitemid 23059447)
17. Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors. M Brozova Z Kleibl I Netikova J Sevcik E Scholzova J Brezinova A Chaloupkova P Vesely P Dundr M Zadinova, et al. Breast Cancer Res Treat 2007 103 247 257 10.1007/s10549-006- 9358-x 17063277 (Pubitemid 46789138)
18. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Taylor-Papadimitriou M Stampfer J Bartek A Lewis M Boshell EB Lane IM Leigh, J Cell Sci 1989 94 Pt 3 403 413 2483723 (Pubitemid 20002838)
19. A gene-expression signature as a predictor of survival in breast cancer. MJ van de Vijver YD He LJ van't Veer H Dai AA Hart DW Voskuil GJ Schreiber JL Peterse C Roberts MJ Marton, et al. N Engl J Med 2002 347 1999 2009 10.1056/NEJMoa021967 12490681 (Pubitemid 35461656)
20. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. AF Gazdar V Kurvari A Virmani L Gollahon M Sakaguchi M Westerfield D Kodagoda V Stasny HT Cunningham II Wistuba, et al. Int J Cancer 1998 78 766 774 10.1002/(SICI)1097-0215(19981209)78:6<766::AID- IJC15>3.0.CO;2-L 9833771 (Pubitemid 28530401)
21. The epithelial-mesenchymal transition generates cells with properties of stem cells. SA Mani W Guo MJ Liao EN Eaton A Ayyanan AY Zhou M Brooks F Reinhard CC Zhang M Shipitsin, et al. Cell 2008 133 704 715 10.1016/j.cell.2008.03.027 18485877 (Pubitemid 351636299)
22. It's all in the details: methods in breast development and cancer. M Bentires-Alj RB Clarke J Jonkers M Smalley T Stein, Breast Cancer Res 2009 11 305 10.1186/bcr2346 19691817
23. Complex cytokeratin polypeptide patterns observed in certain human carcinomas. R Moll R Krepler WW Franke, Differentiation 1983 23 256 269 6189757 (Pubitemid 13090321)
24. The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures. L Zhou Y Jiang T Yan G Di Z Shen Z Shao J Lu, Breast Cancer Res Treat 122 795 801
25. ALDH1 expression correlates with favorable prognosis in ovarian cancers. B Chang G Liu F Xue DG Rosen L Xiao X Wang J Liu, Mod Pathol 2009 22 817 823 19329942
26. Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. A Magnifico L Albano S Campaner D Delia F Castiglioni P Gasparini G Sozzi E Fontanella S Menard E Tagliabue, Clin Cancer Res 2009 15 2010 2021 10.1158/1078-0432.CCR-08- 1327 19276287
27. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells. TM Trost EU Lausch SA Fees S Schmitt T Enklaar D Reutzel LR Brixel P Schmidtke M Maringer IB Schiffer, et al. Cancer Res 2005 65 840 849 15705882 (Pubitemid 40216443)
28. Role of HER2/neu in tumor progression and therapy. S Menard P Casalini M Campiglio SM Pupa E Tagliabue, Cell Mol Life Sci 2004 61 2965 2978 10.1007/s00018-004-4277-7 15583858 (Pubitemid 40104594)